Today: 3 March 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Royal Bank of Canada (RY, RY.TO) Stock: Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

Royal Bank of Canada (RY, RY.TO) Stock: Q4 2025 Earnings Beat, Dividend Hike and 2026 Outlook

Royal Bank of Canada reported record fiscal 2025 results, with Q4 net income rising 29% to C$5.43 billion and adjusted EPS of C$3.85, beating expectations. Shares closed near all-time highs at about C$216 in Toronto. Capital markets and wealth management divisions drove gains, while provisions for credit losses rose to just over C$1 billion. RBC raised its dividend and lifted its 2026 profitability target.
Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy (SU) Stock: Dividend Hike, Q3 2025 Beat and Analyst Outlook as of December 3, 2025

Suncor Energy shares traded near US$44 on December 3, 2025, down about 2% intraday but close to a 52-week high. The stock went ex-dividend for an increased C$0.60 quarterly payout, following record Q3 production and earnings that led to raised 2025 guidance. Analysts raised price targets, with consensus in the C$65–66 range. Suncor’s market cap stands near US$53 billion.
Canadian Natural Resources (CNQ) Stock on December 3, 2025: Price, Dividend Yield and Outlook After Record Q3 Results

Canadian Natural Resources (CNQ) Stock on December 3, 2025: Price, Dividend Yield and Outlook After Record Q3 Results

Canadian Natural Resources traded near C$46.94 in Toronto and US$33.55 in New York on December 3, 2025, close to its 52-week highs and yielding about 5%. The company posted record Q3 production and returned over C$6 billion to shareholders year-to-date. Major holders, including Arrowstreet Capital and 1832 Asset Management, trimmed stakes. Institutional ownership remains around 74%.
Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health (ELV) Stock: December 2025 Outlook After Q3 Earnings Beat, Legal Headwinds and New Analyst Targets

Elevance Health shares traded near $331 early December 3, about 30% below their 52-week high despite a strong Q3 earnings report. The stock is down 18% over the past year, underperforming the S&P 500. Q3 operating revenue rose 12% to $50.1 billion, with net income up nearly 18% to $1.2 billion. Shares fell 2.5% at the start of December before stabilizing.
3 December 2025
Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas Corporation closed at $184.19 on December 2, 2025, near its 52-week low and down about 17% over the past year, despite continued revenue growth and strong margins. Arrowstreet Capital, Panagora Asset Management, and Edgestream Partners have all increased their stakes in recent filings. Cintas’ market cap stands near $75 billion, with the stock trading at over 40 times trailing earnings.
3 December 2025
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M shares closed at $171.56 on December 2, 2025, near a four-year high and up about 31% over the past year. Technical models show short-term bullish momentum, but long-term forecasts from CoinCodex and StockScan project a possible decline to around $133 by 2026–2030. The company’s market cap stands at $91 billion with a dividend yield of 1.7%. Investors remain split over legal risks and recent gains.
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

A U.S. judge on Dec. 1, 2025, revived a $6.7 billion lawsuit against Bristol-Myers Squibb over Celgene contingent value rights, sending BMY shares down 1.89% to $48.25. The stock marked its third straight loss, underperforming peers as legal risks weighed despite positive hematology data at ASH 2025. Market cap stood at about $98 billion. Trading volume was below average at 14.5 million shares.
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management shares closed at $132.08 on December 2, 2025, up 0.53%, with after-hours trading lifting the price to $132.80. The firm confirmed $908 billion in assets under management as of September 30. CEO Marc Rowan is set to appear at the Goldman Sachs US Financial Services Conference on December 10. Apollo’s market cap stood at about $76.3 billion.
3 December 2025
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health shares fell 1.9% to $77.62 on December 2, 2025, underperforming the S&P 500 and healthcare peers after news of a $37.76 million federal settlement over insulin-pen billing. Trading volume topped 7.7 million shares, above average. The stock remains up about 75–80% for the year but sits roughly 8–9% below its late October high. CVS did not admit liability in the settlement.
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group reported near-record trading volumes and received SEC approval for a new securities clearing house on December 2, 2025. Shares closed at $277.49, down 0.5%. The company continues to address fallout from last week’s 10-hour trading outage. CME declared a Q4 dividend of $1.25 per share, with total distributions over the past year estimated at $10.80 per share.
3 December 2025
ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips (COP) Stock in December 2025: Dividend Hike, Layoffs and 2026 Outlook After Q3 Earnings Beat

ConocoPhillips closed at $89.29 on December 2, down 1.07%, underperforming the S&P 500 and Dow. The stock sits about 17% below its 52-week high, with a market cap near $110 billion. Q3 2025 net income fell to $1.7 billion from $2.1 billion a year earlier, but adjusted EPS of $1.61 beat estimates. Analysts’ 12-month price targets imply 25–30% upside from current levels.
HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare Stock Near Record Highs: December 2025 Earnings, Forecasts and Policy Risks Explained

HCA Healthcare stock closed near $503 on December 2, 2025, up over 38% from its July peak, following record Q3 results and raised guidance. Q3 revenue rose 9.6% to $19.2 billion, with net income up 29% to $1.64 billion. The company repurchased 6.5 million shares in Q3 and maintained a quarterly dividend of $0.72 per share. Market cap stands around $117 billion.
Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation (BN) Stock: Fresh News, AI and Energy Transition Bets, and Wall Street Forecasts as of December 2, 2025

Brookfield Corporation closed at US$46.46 on the NYSE and C$65.01 on the TSX on December 2, 2025, valuing the company at over US$100 billion. HSBC Holdings increased its stake by 3.7% in Q2, while institutional ownership in Brookfield now exceeds 60%. The board declared a US$0.06 quarterly dividend, payable December 31. BN shares are up about 16% over the past year.
Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings (BKNG) Stock News & Forecast for December 2025: Q3 Beat, AI Tailwinds and a 20% Upside Gap

Booking Holdings shares surged nearly 5% on December 2, 2025, closing at $5,135.07 after Q3 results beat expectations and management raised guidance. Several institutional investors disclosed new 13F filings the same day, with some increasing and others reducing positions. Wall Street targets imply 19–21% upside, but technical models warn of a possible 14% pullback in the next three months.
TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX Stock (NYSE:TJX) in December 2025: Q3 FY26 Beat, New Analyst Price Targets and What Comes Next

TJX shares closed at $150.02 on December 2, 2025, just below their record high of $154.66, giving the retailer a market cap near $167 billion. The stock has climbed over 26% year-to-date, hitting an all-time high on November 26. Technical analysts downgraded TJX from “Buy” to “Hold/Accumulate” after a three-day slide. Volatility remains low, with daily moves averaging under 2% last week.
BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock (BLK) Stock on December 2, 2025: Price, AI Outlook, Bitcoin ETF Boom and 2026 Forecast

BlackRock shares closed at $1,038.62 on December 2, 2025, down 0.13% and flat for the year. The firm’s 2026 outlook turned bearish on long-term U.S. Treasuries, citing AI-driven borrowing and rising public debt, while remaining overweight on U.S. equities. Market cap stands at $166.8 billion. Trading volume was about 261,000 shares, slightly below average.
Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton (ETN) Stock Outlook on December 2, 2025: Boyd Thermal Deal, AI Data Centers and Analyst Targets

Eaton shares closed at $333 on December 2, 2025, down 1.9% for the day and 16% below their 52-week high, despite record Q3 earnings and margins. The stock has fallen 11% over the past year, underperforming the S&P 500 and industrial peers. Eaton recently agreed to acquire Boyd Thermal for $9.5 billion and is expanding U.S. manufacturing amid strong demand from AI and electrification trends.
3 December 2025
Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block (NYSE: XYZ, Formerly SQ) Stock Slides Despite Strong Black Friday Data: Latest News, Forecasts & 2025–2028 Outlook (2 December 2025)

Block, Inc. shares fell 6.6% to close at $60.11 on December 2, 2025, despite reporting record Black Friday–Cyber Monday volumes. The company processed over 124 million transactions, up 10% year-over-year, but trading volume surged to 20.7 million shares, nearly triple the 30-day average. Block’s market cap stands at about $39 billion, well below its 52-week high.
3 December 2025
1 640 641 642 643 644 682
Go toTop